AT303971B - Verfahren zur Herstellung einer Suspension von Chloramphenicol-palmitat in mikrokristalliner Form - Google Patents

Verfahren zur Herstellung einer Suspension von Chloramphenicol-palmitat in mikrokristalliner Form

Info

Publication number
AT303971B
AT303971B AT1052270A AT1052270A AT303971B AT 303971 B AT303971 B AT 303971B AT 1052270 A AT1052270 A AT 1052270A AT 1052270 A AT1052270 A AT 1052270A AT 303971 B AT303971 B AT 303971B
Authority
AT
Austria
Prior art keywords
suspension
preparation
microcrystalline form
chloramphenicol palmitate
chloramphenicol
Prior art date
Application number
AT1052270A
Other languages
English (en)
Original Assignee
Yamanouchi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharma Co Ltd filed Critical Yamanouchi Pharma Co Ltd
Application granted granted Critical
Publication of AT303971B publication Critical patent/AT303971B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K23/00—Use of substances as emulsifying, wetting, dispersing, or foam-producing agents
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K23/00—Use of substances as emulsifying, wetting, dispersing, or foam-producing agents
    • C09K23/34—Higher-molecular-weight carboxylic acid esters
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K23/00—Use of substances as emulsifying, wetting, dispersing, or foam-producing agents
    • C09K23/42—Ethers, e.g. polyglycol ethers of alcohols or phenols

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT1052270A 1969-12-04 1970-11-23 Verfahren zur Herstellung einer Suspension von Chloramphenicol-palmitat in mikrokristalliner Form AT303971B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9731069 1969-12-04

Publications (1)

Publication Number Publication Date
AT303971B true AT303971B (de) 1972-12-27

Family

ID=14188900

Family Applications (1)

Application Number Title Priority Date Filing Date
AT1052270A AT303971B (de) 1969-12-04 1970-11-23 Verfahren zur Herstellung einer Suspension von Chloramphenicol-palmitat in mikrokristalliner Form

Country Status (4)

Country Link
AT (1) AT303971B (de)
DE (1) DE2058164A1 (de)
FR (1) FR2072783A5 (de)
GB (1) GB1327591A (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0316567A (pt) * 2002-11-26 2005-10-04 Ciba Sc Holding Ag Antioxidantes fenólicos na forma cristalina

Also Published As

Publication number Publication date
DE2058164A1 (de) 1971-06-16
GB1327591A (en) 1973-08-22
FR2072783A5 (de) 1971-09-24

Similar Documents

Publication Publication Date Title
AT298508B (de) Verfahren zur Herstellung von Mercaptoalkylalkoxysilanen
CH539642A (de) Verfahren zur Herstellung von Pyrimidinylpyrazolderivaten
AT302277B (de) Verfahren zur Herstellung von Chinondiiminen
CH526566A (de) Verfahren zur Herstellung von 5-Pyridyl-2-imidazolonen
CH508604A (de) Verfahren zur Herstellung von Ureidophenylguanidinen
CH521934A (de) Verfahren zur Herstellung von Buten-2-ol-4-Derivaten
CH533084A (de) Verfahren zur Herstellung von Carbonsäureamiden
AT304774B (de) Verfahren zur Herstellung von 16β-Methyl-9α-fluor-steroiden
CH525881A (de) Verfahren zur Herstellung von 4-Alkylprolinen
AT303971B (de) Verfahren zur Herstellung einer Suspension von Chloramphenicol-palmitat in mikrokristalliner Form
AT296961B (de) Verfahren zur Herstellung von Alkyldihydroxybenzolen
AT319485B (de) Verfahren zur Herstellung von 19-Norsteroiden
CH511225A (de) Verfahren zur Herstellung von Amidophenylthioharnstoffen
CH529108A (de) Verfahren zur Herstellung von y-Cyanbutyraldiminen
AT308086B (de) Verfahren zur Herstellung von 1-Alkoxyanthrachinonen
CH513121A (de) Verfahren zur Herstellung von Carbonsäureamiden
CH532069A (de) Verfahren zur Herstellung von 3-Hydroxyisoxazolderivaten
AT299905B (de) Verfahren zur Herstellung von β-Acetoxypivalinaldehyd
AT296297B (de) Verfahren zur Herstellung von N-Tritylimidazolen und -triazolen
CH530358A (de) Verfahren zur Herstellung von 2-Methyl-4-halogen-but-2-en-1-alen
AT297634B (de) Verfahren zur Herstellung einer Glukoisomerase-Zubereitung
CH535200A (de) Verfahren zur Herstellung von o-(B-Diäthylaminoäthoxy)-B-phenylpropiophenon
AT299252B (de) Verfahren zur Herstellung von Organo-H-chlorsilanen
AT299251B (de) Verfahren zur Herstellung von Organo-H-chlorsilanen
AT299907B (de) Verfahren zur Herstellung von Trimethyl-2-cyclohexen-1-onen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee